Sitagliptin added to stable insulin therapy with or without metformin in Chinese patients with type 2 diabetes-Reference-Cited by-同舟云学术

Sitagliptin added to stable insulin therapy with or without metformin in Chinese patients with type 2 diabetes

Author:

Shankar R Ravi¹,Bao Yuqian²,Han Ping³,Hu Ji⁴,Ma Jianhua⁵,Peng Yongde⁶,Wu Fan⁷,Xu Lei¹,Engel Samuel S¹,Jia Weiping²

Affiliation:

1. Merck & Co., Inc.; Kenilworth New Jersey USA

2. Shanghai Jiao Tong University Affiliated Sixth People's Hospital; Shanghai

3. Shengjing Hospital of China Medical University; Shenyang

4. The Second Affiliated Hospital of Soochow University; Suzhou

5. Nanjing First Hospital Affiliated to Nanjing Medical University; Nanjing

6. Shanghai First People's Hospital affiliated to Shanghai Jiaotong University; Shanghai

7. MSD China; Beijing China

Funder

Merck

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

Reference27 articles.

1. IDF Diabetes Atlas 6th edn Brussels, Belgium International Diabetes Federation http://www.idf.org/sites/default/files/Atlas-poster-2014_EN.pdf

4. Morning insulin glargine is better than bedtime insulin glargine or bedtime NPH insulin in combination with glimepiride;Fritsch;JCOM,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2019-08